Science Explorer Back to mapMap
Discussion
Company · Malvern · United States

Endo Pharmaceuticals (United States)

In research, Endo Pharmaceuticals (United States) stands highest in Health Sciences (#7,959 of 16,688 worldwide) and Medicine (#7,128 of 14,558 worldwide), over all time.

World rank, all time
#20,241
of 34,923
Rank in United States
#4,201
of 7,310
Research works
376
▲ 9% vs 2018-21
Citations
6.8k
18.2 per fractional work
Top-10% rate
8.3%
all institutions 10.0%
vs its own fields
0.90×
1.00× is exactly expected
Open access
42%
world 40%
International
30%
world 18%

What is Endo Pharmaceuticals (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #7,959 of 16,688 8.5%219
MedicineField #7,128 of 14,558 8.3%201

Each strip is that field's whole ranked pool, with the notch where Endo Pharmaceuticals (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Endo Pharmaceuticals (United States) work in?

In 2022-now, 44% of research at Endo Pharmaceuticals (United States) is in Health Sciences, 27% in Social Sciences. Its largest fields are Medicine (38%), Social Sciences (13%), Biochemistry, Genetics and Molecular Biology (8%). It does 1.7× the world's share of Health Sciences.

Health Sciences: 22 fractional works · 43.7% of its workMedicine: 20 fractional works · 38.1% of its workSurgery: 4 fractional works · 7.7% of its workPulmonary and Respiratory Medicine: 2 fractional works · 4.4% of its workPsychiatry and Mental health: 2 fractional works · 3.3% of its workRheumatology: 2 fractional works · 3.0% of its workReproductive Medicine: 1 fractional works · 2.8% of its workPhysiology: 1 fractional works · 2.3% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.0% of its workEpidemiology: 1 fractional works · 1.7% of its workNeurology: 1 fractional works · 1.3% of its workDermatology: 1 fractional works · 1.2% of its workPharmacology: 1 fractional works · 1.2% of its workGastroenterology: 0 fractional works · 1.0% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.0% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.9% of its workUrology: 0 fractional works · 0.7% of its workPathology and Forensic Medicine: 0 fractional works · 0.6% of its workInfectious Diseases: 0 fractional works · 0.5% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workHealth Informatics: 0 fractional works · 0.3% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.3% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 1.0% of its workHealth Professions: 3 fractional works · 5.1% of its workGeneral Health Professions: 1 fractional works · 2.2% of its workHealth Information Management: 1 fractional works · 1.6% of its workComplementary and Manual Therapy: 0 fractional works · 0.6% of its workRadiological and Ultrasound Technology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 0.1% of its workDentistry: 0 fractional works · 0.1% of its workSocial Sciences: 14 fractional works · 26.9% of its workSocial Sciences: 7 fractional works · 13.1% of its workSociology and Political Science: 1 fractional works · 2.5% of its workGender Studies: 1 fractional works · 2.2% of its workEducation: 1 fractional works · 2.0% of its workPolitical Science and International Relations: 1 fractional works · 1.4% of its workLaw: 1 fractional works · 1.2% of its workCommunication: 0 fractional works · 1.0% of its workAnthropology: 0 fractional works · 0.8% of its workHealth: 0 fractional works · 0.8% of its workUrban Studies: 0 fractional works · 0.4% of its workLinguistics and Language: 0 fractional works · 0.3% of its workDemography: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPsychology: 3 fractional works · 5.8% of its workClinical Psychology: 2 fractional works · 3.2% of its workExperimental and Cognitive Psychology: 1 fractional works · 1.0% of its workSocial Psychology: 0 fractional works · 0.9% of its workApplied Psychology: 0 fractional works · 0.6% of its workBusiness, Management and Accounting: 1 fractional works · 2.7% of its workOrganizational Behavior and Human Resource Management: 1 fractional works · 2.3% of its workStrategy and Management: 0 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.9% of its workEconomics and Econometrics: 1 fractional works · 1.6% of its workGeneral Economics, Econometrics and Finance: 0 fractional works · 0.3% of its workDecision Sciences: 1 fractional works · 1.8% of its workStatistics, Probability and Uncertainty: 0 fractional works · 1.0% of its workInformation Systems and Management: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workArts and Humanities: 1 fractional works · 1.6% of its workReligious studies: 0 fractional works · 0.5% of its workArcheology: 0 fractional works · 0.5% of its workLiterature and Literary Theory: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 8 fractional works · 15.7% of its workEngineering: 4 fractional works · 7.1% of its workControl and Systems Engineering: 1 fractional works · 1.9% of its workMechanical Engineering: 1 fractional works · 1.7% of its workBuilding and Construction: 1 fractional works · 1.0% of its workCivil and Structural Engineering: 0 fractional works · 0.6% of its workBiomedical Engineering: 0 fractional works · 0.5% of its workMechanics of Materials: 0 fractional works · 0.4% of its workElectrical and Electronic Engineering: 0 fractional works · 0.3% of its workAerospace Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workComputer Science: 2 fractional works · 4.3% of its workComputer Networks and Communications: 1 fractional works · 2.2% of its workInformation Systems: 0 fractional works · 0.9% of its workComputational Theory and Mathematics: 0 fractional works · 0.7% of its workArtificial Intelligence: 0 fractional works · 0.2% of its workSignal Processing: 0 fractional works · 0.2% of its workMaterials Science: 2 fractional works · 3.0% of its workPolymers and Plastics: 1 fractional works · 2.7% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workEnvironmental Science: 1 fractional works · 1.0% of its workGlobal and Planetary Change: 0 fractional works · 0.4% of its workManagement, Monitoring, Policy and Law: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workChemistry: 0 fractional works · 0.2% of its workOrganic Chemistry: 0 fractional works · 0.2% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workLife Sciences: 7 fractional works · 13.8% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 8.2% of its workMolecular Biology: 3 fractional works · 6.6% of its workGenetics: 1 fractional works · 1.3% of its workBiochemistry: 0 fractional works · 0.3% of its workImmunology and Microbiology: 1 fractional works · 2.6% of its workImmunology: 1 fractional works · 2.2% of its workMicrobiology: 0 fractional works · 0.3% of its workParasitology: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.2% of its workToxicology: 0 fractional works · 0.8% of its workPharmacology: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 0 fractional works · 0.9% of its workPlant Science: 0 fractional works · 0.4% of its workSoil Science: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.8% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workALL ITS WORKEndoPharmaceuticals…51fractional works, 2022-now
Life Sciences14%Physical Sciences16%Health Sciences44%Social Sciences27%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Medicine2038.1%
    2. Health Professions35.1%
    3. Veterinary00.3%
    4. Nursing00.1%
    5. Dentistry00.1%
    1. Social Sciences713.1%
    2. Psychology35.8%
    3. Business, Management and Accounting12.7%
    4. Economics, Econometrics and Finance11.9%
    5. Decision Sciences11.8%
    6. Arts and Humanities11.6%
    1. Engineering47.1%
    2. Computer Science24.3%
    3. Materials Science23.0%
    4. Environmental Science11.0%
    5. Chemistry00.2%
    6. Physics and Astronomy00.1%
    1. Biochemistry, Genetics and Molecular Biology48.2%
    2. Immunology and Microbiology12.6%
    3. Pharmacology, Toxicology and Pharmaceutics11.2%
    4. Agricultural and Biological Sciences00.9%
    5. Neuroscience00.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.19× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.54× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 2.63× its world share, 1 worksImmunology and Micro…Neuroscience: 0.50× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.28× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.14× its world share, 0 worksChemistryComputer Science: 0.55× its world share, 2 worksComputer ScienceEngineering: 0.48× its world share, 4 worksEngineeringEnvironmental Science: 0.20× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.86× its world share, 2 worksMaterials SciencePhysics and Astronomy: 0.02× its world share, 0 worksPhysics and AstronomyDentistry: 0.19× its world share, 0 worksDentistryHealth Professions: 1.94× its world share, 3 worksHealth ProfessionsMedicine: 1.98× its world share, 20 worksMedicineNursing: 0.26× its world share, 0 worksNursingVeterinary: 1.89× its world share, 0 worksVeterinaryArts and Humanities: 0.56× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 0.83× its world share, 1 worksBusiness, Management…Decision Sciences: 1.88× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 0.91× its world share, 1 worksEconomics, Econometr…Psychology: 1.90× its world share, 3 worksPsychologySocial Sciences: 1.03× its world share, 7 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 3.3×. Every wedge is a field page.

All 22 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics3.28×1 works
  2. Immunology and Microbiology2.63×1 works
  3. Medicine1.98×20 works
  4. Health Professions1.94×3 works
  5. Psychology1.90×3 works
  6. Veterinary1.89×0 works
  7. Decision Sciences1.88×1 works
  8. Biochemistry, Genetics and Molecular Biology1.54×4 works
  9. Social Sciences1.03×7 works
  10. Economics, Econometrics and Finance0.91×1 works
  11. Materials Science0.86×2 works
  12. Business, Management and Accounting0.83×1 works
  13. Arts and Humanities0.56×1 works
  14. Computer Science0.55×2 works
  15. Neuroscience0.50×0 works
  16. Engineering0.48×4 works
  17. Nursing0.26×0 works
  18. Environmental Science0.20×0 works
  19. Agricultural and Biological Sciences0.19×0 works
  20. Dentistry0.19×0 works
  21. Chemistry0.14×0 works
  22. Physics and Astronomy0.02×0 works

Who are the top researchers at Endo Pharmaceuticals (United States)?

Ranked on the quality score, Arnold R. Gammaitoni, John C. Campbell and Gregory J. Kaufman lead among researchers whose main affiliation is Endo Pharmaceuticals (United States).

  1. 1 Arnold R. Gammaitoni United States · #661,732 worldwide 5.3k citations · 167 works
  2. 2 John C. Campbell United States · #852,533 worldwide 2.4k citations · 131 works
  3. 3 Gregory J. Kaufman United States · #1,055,050 worldwide 1.6k citations · 41 works
  4. 4 Michael P. McLane United States · #1,441,501 worldwide 2.4k citations · 80 works
  5. 5 Morris Pfeffer United States · #1,955,219 worldwide 809 citations · 22 works
  6. 6 C. F. Hiskey United States · #2,046,643 worldwide 874 citations · 42 works
  7. 7 Napoleon A. Oleka United States · #2,226,869 worldwide 814 citations · 18 works
  8. 8 David C. Hurley United States · #2,258,024 worldwide 810 citations · 50 works
  9. 9 Tina Ma United States · #2,287,716 worldwide 834 citations · 19 works
  10. 10 Harold Blumberg United States · #2,511,349 worldwide 603 citations · 32 works
All ranked researchers at Endo Pharmaceuticals (United States)

What are the most cited papers from Endo Pharmaceuticals (United States)?

The most cited paper from Endo Pharmaceuticals (United States) is "Core outcome measures for chronic pain clinical trials: IMMPACT recommendations" (Robert H. Dworkin et al., 2004), with 3,789 citations. Next come "Core outcome domains for chronic pain clinical trials: IMMPACT recommendations" (3,518) and "Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations" (3,496).

Most cited papers
#PaperReleasedCitations
1 Core outcome measures for chronic pain clinical trials: IMMPACT recommendations Robert H. Dworkin et al. · Pain 6 Nov 2004 3,789
2 Core outcome domains for chronic pain clinical trials: IMMPACT recommendations Dennis C. Turk et al. · Pain 22 Sep 2003 3,518
3 Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations Robert H. Dworkin et al. · Journal of Pain Open access 13 Dec 2007 3,496
4 Perspectives on cancer therapy-induced mucosal injury Stephen T. Sonis, Linda S. Elting, Dorothy M. K. Keefe et al. · Cancer Open access 2004 1,420
5 Core Outcome Domains and Measures for Pediatric Acute and Chronic/Recurrent Pain Clinical Trials: PedIMMPACT Recommendations Patrick J. McGrath et al. · Journal of Pain Open access 18 Jun 2008 862
All 62 most cited papers, with filters and sorting

Which keywords describe research at Endo Pharmaceuticals (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology, Treatment, Management, Erectile Dysfunction, Sexual Dysfunction, Genetic Susceptibility, Diagnosis and Pathophysiology.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 37 words, with their numbers
  1. Epidemiology6▲ 3.0×24 topics
  2. Treatment2▲ 4.0×12 topics
  3. Quality of Life2▲ 3.1×9 topics
  4. Management2▲ 5.3×5 topics
  5. Cardiovascular Disease2▲ 3.5×7 topics
  6. Diagnosis2▲ 4.3×6 topics
  7. Inflammation2▲ 1.96×8 topics
  8. Artificial Intelligence2▲ 2.6×4 topics
  9. Erectile Dysfunction2▲ 103×1 topic
  10. Genetic Susceptibility2▲ 33×2 topics
  11. Pathophysiology2▲ 10×4 topics
  12. Sexual Dysfunction2▲ 103×1 topic
  13. Surgical Management2▲ 7.6×4 topics
  14. HIV Prevention2▲ 48×2 topics
  15. Surgical Treatment2▲ 15×3 topics
  16. Infertility1▲ 19×2 topics
  17. Security1▲ 4.2×3 topics
  18. Collagenase Clostridium Histolyticum1▲ 440×1 topic
  19. Fasciectomy1▲ 440×1 topic
  20. Globalization1▲ 1.28×9 topics
  21. Immunobiology1▲ 53×1 topic
  22. Stem Cells1▲ 9.2×1 topic
  23. Genetics1▲ 3.4×5 topics
  24. Mental Health1▲ 1.57×9 topics
  25. Organizational Change1▲ 28×3 topics
  26. Risk Factors1▲ 2.2×6 topics
  27. Asthma1▲ 21×2 topics
  28. Complications1▲ 4.2×6 topics
  29. Immunology1▲ 19×2 topics
  30. Sexually Transmitted Infections1▲ 41×2 topics
  31. Virtual Reality1▲ 4.2×2 topics
  32. Cloud Robotics1▲ 73×1 topic
  33. Internet of Robotic Things1▲ 73×1 topic
  34. Male Circumcision1▲ 86×1 topic
  35. Mobile Agents1▲ 195×1 topic
  36. Network Management1▲ 60×1 topic
  37. Penile Cancer1▲ 86×1 topic

Which research topics does Endo Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Sexual function and dysfunction studies, Endometriosis Research and Treatment, Dupuytren's Contracture and Treatments and Genital Health and Disease.

  1. 1 Sexual function and dysfunction studies Psychiatry and Mental health 2 works
  2. 2 Endometriosis Research and Treatment Reproductive Medicine 1 works
  3. 3 Dupuytren's Contracture and Treatments Rheumatology 1 works
  4. 4 Genital Health and Disease Surgery 1 works
  5. 5 Mobile Agent-Based Network Management Computer Networks and Communications 1 works
  6. 6 Robotics and Automated Systems Control and Systems Engineering 1 works
  7. 7 Asthma and respiratory diseases Physiology 1 works
  8. 8 Epigenetics and DNA Methylation Molecular Biology 1 works
  9. 9 Connective Tissue Growth Factor Research Molecular Biology 1 works
  10. 10 Management and Organizational Studies Organizational Behavior and Human Resource Management 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.1%not open57.9%

World: 40% of research is openly available.

with international co-authors30.4%domestic only69.6%

World: 18% is written across borders.

How has Endo Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 9% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Endo Pharmaceuticals (United States) as a percentage of every work published that year, 0.00019% in 2024.

still counting0.0010%0.0020%Endo Pharmaceuticals (United States)0.00022% in 202519801990200020102020

Fractional works of Endo Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Malvern

All research institutions in Malvern

Share Endo Pharmaceuticals (United States)'s ranking

Endo Pharmaceuticals (United States) on Science Explorer

A card with Endo Pharmaceuticals (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Endo Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.